Continuous renal replacement therapy (CRRT) is a type of dialysis that provides slow, continuous blood filtration to help regulate fluid, electrolyte, and waste levels in critically ill patients with acute kidney injury (AKI) who are hemodynamically unstable. It helps manage fluid overload in critically ill patients, particularly those who cannot tolerate rapid fluid removal by intermittent hemodialysis due to cardiovascular instability.
Sizing and Forecast
The continuous renal replacement therapy market size has grown rapidly in recent years. It will grow from $1.41 billion in 2023 to $1.57 billion in 2024 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to increased demand for advanced CRRT devices, an increase in the prevalence of incidence of acute kidney injury, a rise in the number of medical applications, a high prevalence of co-morbidities, and continuous research and development.
The continuous renal replacement therapy market size is expected to see rapid growth in the next few years. It will grow to $2.38 billion in 2028 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to increasing incidences of chronic kidney diseases, rising prevalence of diabetes, a growing number of ICU admissions, rising investments in healthcare infrastructure, and expanding applications in pediatric care. Major trends in the forecast period include rapid advancements, launches of new technologies, technological advancements, product innovation, and technologically advanced CRRT products.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/continuous-renal-replacement-therapy-global-market-report
Segmentation & Regional Insights
The continuous renal replacement therapy market covered in this report is segmented –
1) By Product: System, Consumables
2) By Therapy: Renal, Non-Renal
3) By Modality: Slow Continuous Ultra-Filtration (SCUF), Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodialysis (CVVHD), Continuous Venovenous Hemodiafiltration (CVVHDF)
4) By Age Group: Adults, Pediatrics Or Neonates
5) By End-Users: Hospitals, Ambulatory Care, Homecare
North America was the largest region in the continuous renal replacement therapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the continuous renal replacement therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15777&type=smp
Major Driver Impacting Market Growth
The increasing incidence of chronic kidney diseases is expected to propel the growth of the continuous renal replacement therapy market going forward. Chronic kidney disease (CKD) is a long-term condition where the kidneys progressively lose function over time, leading to impaired filtration of waste products from the blood. The rising incidence of chronic kidney diseases is influenced by lifestyle changes, aging populations, and increasing rates of diabetes and hypertension. Continuous renal replacement therapy is utilized in chronic kidney disease for acute exacerbations or complications to manage fluid balance and continuously remove metabolic waste products. For instance, in July 2022, according to the Centers for Disease Control and Prevention, a US-based national public health agency, around 15%, or 37 million people in the US, were affected by kidney disease. Furthermore, according to a report from the Australian Institute of Health and Welfare, an Australia-based government agency, the prevalence of kidney replacement therapy in 2020 was 95.4 (per 100,000 population), up from 94 (per 100,000 population) in 2019. Therefore, the increasing incidence of chronic kidney diseases is driving the growth of the continuous renal replacement therapy market.
Key Industry Players
Major companies operating in the continuous renal replacement therapy market are Medtronic Plc, Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Corporation, Toray Industries Inc., Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, NxStage Medical Inc., Hillrom Holdings Inc., Gambro AB, JMS Co. Ltd., Quanta Dialysis Technologies Ltd., Bellco S.r.l., Ningbo Tianyi Medical Devices Co. Ltd., Cytosorbents Corporation, Kawasumi Laboratories Inc., Medica S.p.A., Infomed SA , Medites Pharma Spol. S.R.O, Nikkiso Co. Ltd., Anjue Medical Equipment Co. Ltd., Medcomp Systems Ltd.
The continuous renal replacement therapy market report table of contents includes:
1. Executive Summary
2. Continuous Renal Replacement Therapy Market Characteristics
3. Continuous Renal Replacement Therapy Market Trends And Strategies
4. Continuous Renal Replacement Therapy Market – Macro Economic Scenario
5. Global Continuous Renal Replacement Therapy Market Size and Growth
….
32. Global Continuous Renal Replacement Therapy Market Competitive Benchmarking
33. Global Continuous Renal Replacement Therapy Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Continuous Renal Replacement Therapy Market
35. Continuous Renal Replacement Therapy Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
